ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - melphalan - טבליה - melphalan 2 mg - melphalan - melphalan - for the palliative treatment of multiple myeloma and of non-epithelial carcinoma of the ovary.

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - melphalan - אבקה וממס להכנת תמיסה להזרקה - melphalan 50 mg/vial - melphalan - melphalan - for the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial cancer of the ovary.

ישראל - עברית - Ministry of Health

raz pharmaceutics ltd, israel - melphalan as hydrochloride - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - melphalan as hydrochloride 50 mg - melphalan

ישראל - עברית - Ministry of Health

איי. אל אמרגו ישראל בע"מ - רופא - hepatic delivery system for percutaneous intra-arterial administration of a chemotherapeutic agent (melphalan hydrochlorid)

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ישראל - עברית - Ministry of Health

j-c health care ltd - daratumumab - תרכיז להכנת תמיסה לאינפוזיה - daratumumab 20 mg / 1 ml - daratumumab

ישראל - עברית - Ministry of Health

j-c health care ltd - daratumumab - תמיסה להזרקה - daratumumab 120 mg / 1 ml - daratumumab